Global Hypertension Drugs Market Research Report 2021-2025
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Hypertension Drugs Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).
In this report, the global Hypertension Drugs market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.
The report firstly introduced the Hypertension Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Pfizer
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hypertension Drugs for each application, including-
Hospitals
Clinics
In this report, the global Hypertension Drugs market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.
The report firstly introduced the Hypertension Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Pfizer
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hypertension Drugs for each application, including-
Hospitals
Clinics
PART I HYPERTENSION DRUGS INDUSTRY OVERVIEW
CHAPTER ONE HYPERTENSION DRUGS INDUSTRY OVERVIEW
1.1 Hypertension Drugs Definition
1.2 Hypertension Drugs Classification Analysis
1.2.1 Hypertension Drugs Main Classification Analysis
1.2.2 Hypertension Drugs Main Classification Share Analysis
1.3 Hypertension Drugs Application Analysis
1.3.1 Hypertension Drugs Main Application Analysis
1.3.2 Hypertension Drugs Main Application Share Analysis
1.4 Hypertension Drugs Industry Chain Structure Analysis
1.5 Hypertension Drugs Industry Development Overview
1.5.1 Hypertension Drugs Product History Development Overview
1.5.1 Hypertension Drugs Product Market Development Overview
1.6 Hypertension Drugs Global Market Comparison Analysis
1.6.1 Hypertension Drugs Global Import Market Analysis
1.6.2 Hypertension Drugs Global Export Market Analysis
1.6.3 Hypertension Drugs Global Main Region Market Analysis
1.6.4 Hypertension Drugs Global Market Comparison Analysis
1.6.5 Hypertension Drugs Global Market Development Trend Analysis
CHAPTER TWO HYPERTENSION DRUGS UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Hypertension Drugs Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA HYPERTENSION DRUGS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA HYPERTENSION DRUGS MARKET ANALYSIS
3.1 Asia Hypertension Drugs Product Development History
3.2 Asia Hypertension Drugs Competitive Landscape Analysis
3.3 Asia Hypertension Drugs Market Development Trend
CHAPTER FOUR 2016-2021 ASIA HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2016-2021 Hypertension Drugs Production Overview
4.2 2016-2021 Hypertension Drugs Production Market Share Analysis
4.3 2016-2021 Hypertension Drugs Demand Overview
4.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
4.5 2016-2021 Hypertension Drugs Import Export Consumption
4.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA HYPERTENSION DRUGS KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
6.1 2021-2025 Hypertension Drugs Production Overview
6.2 2021-2025 Hypertension Drugs Production Market Share Analysis
6.3 2021-2025 Hypertension Drugs Demand Overview
6.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
6.5 2021-2025 Hypertension Drugs Import Export Consumption
6.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
PART III NORTH AMERICAN HYPERTENSION DRUGS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN HYPERTENSION DRUGS MARKET ANALYSIS
7.1 North American Hypertension Drugs Product Development History
7.2 North American Hypertension Drugs Competitive Landscape Analysis
7.3 North American Hypertension Drugs Market Development Trend
CHAPTER EIGHT 2016-2021 NORTH AMERICAN HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2016-2021 Hypertension Drugs Production Overview
8.2 2016-2021 Hypertension Drugs Production Market Share Analysis
8.3 2016-2021 Hypertension Drugs Demand Overview
8.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
8.5 2016-2021 Hypertension Drugs Import Export Consumption
8.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN HYPERTENSION DRUGS KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
10.1 2021-2025 Hypertension Drugs Production Overview
10.2 2021-2025 Hypertension Drugs Production Market Share Analysis
10.3 2021-2025 Hypertension Drugs Demand Overview
10.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
10.5 2021-2025 Hypertension Drugs Import Export Consumption
10.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
PART IV EUROPE HYPERTENSION DRUGS INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE HYPERTENSION DRUGS MARKET ANALYSIS
11.1 Europe Hypertension Drugs Product Development History
11.2 Europe Hypertension Drugs Competitive Landscape Analysis
11.3 Europe Hypertension Drugs Market Development Trend
CHAPTER TWELVE 2016-2021 EUROPE HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2016-2021 Hypertension Drugs Production Overview
12.2 2016-2021 Hypertension Drugs Production Market Share Analysis
12.3 2016-2021 Hypertension Drugs Demand Overview
12.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
12.5 2016-2021 Hypertension Drugs Import Export Consumption
12.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE HYPERTENSION DRUGS KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
14.1 2021-2025 Hypertension Drugs Production Overview
14.2 2021-2025 Hypertension Drugs Production Market Share Analysis
14.3 2021-2025 Hypertension Drugs Demand Overview
14.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
14.5 2021-2025 Hypertension Drugs Import Export Consumption
14.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
PART V HYPERTENSION DRUGS MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN HYPERTENSION DRUGS MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Hypertension Drugs Marketing Channels Status
15.2 Hypertension Drugs Marketing Channels Characteristic
15.3 Hypertension Drugs Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN HYPERTENSION DRUGS NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Hypertension Drugs Market Analysis
17.2 Hypertension Drugs Project SWOT Analysis
17.3 Hypertension Drugs New Project Investment Feasibility Analysis
PART VI GLOBAL HYPERTENSION DRUGS INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2016-2021 GLOBAL HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2016-2021 Hypertension Drugs Production Overview
18.2 2016-2021 Hypertension Drugs Production Market Share Analysis
18.3 2016-2021 Hypertension Drugs Demand Overview
18.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
18.5 2016-2021 Hypertension Drugs Import Export Consumption
18.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
19.1 2021-2025 Hypertension Drugs Production Overview
19.2 2021-2025 Hypertension Drugs Production Market Share Analysis
19.3 2021-2025 Hypertension Drugs Demand Overview
19.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
19.5 2021-2025 Hypertension Drugs Import Export Consumption
19.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL HYPERTENSION DRUGS INDUSTRY RESEARCH CONCLUSIONS
CHAPTER ONE HYPERTENSION DRUGS INDUSTRY OVERVIEW
1.1 Hypertension Drugs Definition
1.2 Hypertension Drugs Classification Analysis
1.2.1 Hypertension Drugs Main Classification Analysis
1.2.2 Hypertension Drugs Main Classification Share Analysis
1.3 Hypertension Drugs Application Analysis
1.3.1 Hypertension Drugs Main Application Analysis
1.3.2 Hypertension Drugs Main Application Share Analysis
1.4 Hypertension Drugs Industry Chain Structure Analysis
1.5 Hypertension Drugs Industry Development Overview
1.5.1 Hypertension Drugs Product History Development Overview
1.5.1 Hypertension Drugs Product Market Development Overview
1.6 Hypertension Drugs Global Market Comparison Analysis
1.6.1 Hypertension Drugs Global Import Market Analysis
1.6.2 Hypertension Drugs Global Export Market Analysis
1.6.3 Hypertension Drugs Global Main Region Market Analysis
1.6.4 Hypertension Drugs Global Market Comparison Analysis
1.6.5 Hypertension Drugs Global Market Development Trend Analysis
CHAPTER TWO HYPERTENSION DRUGS UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Hypertension Drugs Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA HYPERTENSION DRUGS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA HYPERTENSION DRUGS MARKET ANALYSIS
3.1 Asia Hypertension Drugs Product Development History
3.2 Asia Hypertension Drugs Competitive Landscape Analysis
3.3 Asia Hypertension Drugs Market Development Trend
CHAPTER FOUR 2016-2021 ASIA HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2016-2021 Hypertension Drugs Production Overview
4.2 2016-2021 Hypertension Drugs Production Market Share Analysis
4.3 2016-2021 Hypertension Drugs Demand Overview
4.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
4.5 2016-2021 Hypertension Drugs Import Export Consumption
4.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA HYPERTENSION DRUGS KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
6.1 2021-2025 Hypertension Drugs Production Overview
6.2 2021-2025 Hypertension Drugs Production Market Share Analysis
6.3 2021-2025 Hypertension Drugs Demand Overview
6.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
6.5 2021-2025 Hypertension Drugs Import Export Consumption
6.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
PART III NORTH AMERICAN HYPERTENSION DRUGS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN HYPERTENSION DRUGS MARKET ANALYSIS
7.1 North American Hypertension Drugs Product Development History
7.2 North American Hypertension Drugs Competitive Landscape Analysis
7.3 North American Hypertension Drugs Market Development Trend
CHAPTER EIGHT 2016-2021 NORTH AMERICAN HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2016-2021 Hypertension Drugs Production Overview
8.2 2016-2021 Hypertension Drugs Production Market Share Analysis
8.3 2016-2021 Hypertension Drugs Demand Overview
8.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
8.5 2016-2021 Hypertension Drugs Import Export Consumption
8.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN HYPERTENSION DRUGS KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
10.1 2021-2025 Hypertension Drugs Production Overview
10.2 2021-2025 Hypertension Drugs Production Market Share Analysis
10.3 2021-2025 Hypertension Drugs Demand Overview
10.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
10.5 2021-2025 Hypertension Drugs Import Export Consumption
10.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
PART IV EUROPE HYPERTENSION DRUGS INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE HYPERTENSION DRUGS MARKET ANALYSIS
11.1 Europe Hypertension Drugs Product Development History
11.2 Europe Hypertension Drugs Competitive Landscape Analysis
11.3 Europe Hypertension Drugs Market Development Trend
CHAPTER TWELVE 2016-2021 EUROPE HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2016-2021 Hypertension Drugs Production Overview
12.2 2016-2021 Hypertension Drugs Production Market Share Analysis
12.3 2016-2021 Hypertension Drugs Demand Overview
12.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
12.5 2016-2021 Hypertension Drugs Import Export Consumption
12.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE HYPERTENSION DRUGS KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
14.1 2021-2025 Hypertension Drugs Production Overview
14.2 2021-2025 Hypertension Drugs Production Market Share Analysis
14.3 2021-2025 Hypertension Drugs Demand Overview
14.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
14.5 2021-2025 Hypertension Drugs Import Export Consumption
14.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
PART V HYPERTENSION DRUGS MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN HYPERTENSION DRUGS MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Hypertension Drugs Marketing Channels Status
15.2 Hypertension Drugs Marketing Channels Characteristic
15.3 Hypertension Drugs Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN HYPERTENSION DRUGS NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Hypertension Drugs Market Analysis
17.2 Hypertension Drugs Project SWOT Analysis
17.3 Hypertension Drugs New Project Investment Feasibility Analysis
PART VI GLOBAL HYPERTENSION DRUGS INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2016-2021 GLOBAL HYPERTENSION DRUGS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2016-2021 Hypertension Drugs Production Overview
18.2 2016-2021 Hypertension Drugs Production Market Share Analysis
18.3 2016-2021 Hypertension Drugs Demand Overview
18.4 2016-2021 Hypertension Drugs Supply Demand and Shortage
18.5 2016-2021 Hypertension Drugs Import Export Consumption
18.6 2016-2021 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL HYPERTENSION DRUGS INDUSTRY DEVELOPMENT TREND
19.1 2021-2025 Hypertension Drugs Production Overview
19.2 2021-2025 Hypertension Drugs Production Market Share Analysis
19.3 2021-2025 Hypertension Drugs Demand Overview
19.4 2021-2025 Hypertension Drugs Supply Demand and Shortage
19.5 2021-2025 Hypertension Drugs Import Export Consumption
19.6 2021-2025 Hypertension Drugs Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL HYPERTENSION DRUGS INDUSTRY RESEARCH CONCLUSIONS
